Stand Up To Cancer Canada

330 Bay Street, Suite 820
Toronto, ON M5H 2S8
Board Chair: Doug Smith
Board Member: Mike Cosentino

Charitable Reg. #:80550 6730 RR0001

STAR RATING

Ci's Star Rating is calculated based on the following independent metrics:

🔓
Unlock Charity Ratings

✔+

FINANCIAL TRANSPARENCY

Audited financial statements for current and previous years available on the charity’s website.

B

RESULTS REPORTING

Grade based on the charity's public reporting of the work it does and the results it achieves.

n/r

DEMONSTRATED IMPACT

The demonstrated impact per dollar Ci calculates from available program information.

NEED FOR FUNDING

Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.

99%

CENTS TO THE CAUSE

For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 99 cents are available for programs.



My anchor

Programs

About Stand Up To Cancer Canada:

Founded in 2014, Stand Up to Cancer Canada (SU2C Canada) raises money for cancer research as well as to fund cancer education and awareness programs in Canada. It was launched (and is licensed) by the U.S.-based Entertainment Industry Foundation, which encourages philanthropy in the entertainment sector. The charity runs a biennial televised fundraising event called the Stand Up to Cancer Telethon that is carried by all major networks in Canada.  

SU2C Canada distributed $947k in research grants in F2019 as well as $671k in grants that were deferred in previous years. The charity’s research grants are supplemented by funding from federal and provincial government health agencies. SU2C Canada funds multidisciplinary Dream Teams that are composed of researchers from different universities and institutions. SU2C Canada currently funds three teams with researchers that come from 15 distinct research institutes across Canada. Dream Teams receive research grants over a four-year funding cycle. 

The Breast Cancer Team, funded in partnership with Canadian Cancer Society, is developing three targeted drugs to treat aggressive forms of breast cancer. The charity’s most recent F2017 annual report indicates that the team received $9 million in funding over four years starting in January 2016.  

The Stem Cell Team studies stem cell abnormalities in brain tumours. Brain tumour cancer stem cells are resistant to therapy and often cause relapsesSU2C Canada’s 2017 annual report indicates that the team received $11.8 million over a four-year period starting in October 2015.  

In spring 2019, SU2C Canada, Canadian Cancer Society, and Canadian Institutes of Health Research launched the Metastatic Breast Cancer Team. This team is investigating a new way to treat metastatic breast cancer by interrupting cancer cells’ abilities to make the necessary proteins for aggressive spread. The team is to receive $6 million in funding – the first funding phase of $2 million supports the initial clinical trial, which is the first human trial of this novel treatment strategy 

SU2C Canada spent $409k on public awareness and education programs in F2019, in addition to $15.7m in donated media for public awareness activities. SU2C Canada runs PSAs to educate Canadians on cancer. In March 2019, SU2C Canada teamed with Canadian Cancer Society to run a PSA called Life in the Face of Cancer that emphasizes the importance of cancer research to get new treatments to patients quickly. The charities used print, TV, radio, out-of-home, and digital platforms to deliver the PSA. SU2C Canada’s most recent telethon ran in September 2018. It was broadcasted by over 70 networks and streaming platforms across Canada and the USA, and over $162.7 million CAD was pledged in the days following the telethon. SU2C Canada recorded receiving $594k in fundraising revenue through the telethon in F2018.

My anchor

Results and Impact

Stand Up to Cancer Canada posts progress reports for each of its funded Dream Teams. The current Stem Cell Team report states that in December 2017, researchers identified two new drugs that can inhibit brain tumour stem cells. The team has also published 3 papers with major research findings in peer-reviewed journals in 2017 and 2018. The Breast Cancer Team has published 4 papers with major findings in peer-reviewed journals in 2017 and 2018. Phase I clinical trials of all three drugs being investigated by the team finished in June 2018. Two of these drugs showed no dose-limiting toxicity and clinical responses, indicating they could proceed to phase II trials. As of January 2019, a phase II trial has started for one drug.  

My anchor

Finances

Stand Up to Cancer Canada is a medium-sized charity that received $1.7m in cash donations in F2019. It received an additional $15.7m in donated media, which increased by 149% from $6.3m in F2018. The audited financial statements disclose that in F2019 (and F2017), donated media was related to public awareness activities and accounted for 92% of total mission spending for the year. IF2018, donated media was related to fundraising (presumably the biennial Stand Up to Cancer telethon) and the charity recorded no costs associated with donated media for public awareness programming. 

In F2019, administrative costs are 1% of total revenue and the audited financial statements report zero fundraising costs. The charity's F2019 T3010 filing was not available at the time of this profile update to obtain fundraising cost informationBased on the audited statements, for every dollar donated to the charity, 99 cents go to the cause. This is outside of Ci’s reasonable range for overhead spending.  

For comparison, in F2018 administrative costs were 3% of total revenue and fundraising costs were 7% of cash donations and special events fundraising (excluding donated media). Per dollar donated, 90 cents went to the cause, which is within Ci’s reasonable range for overhead spending. When donated media associated with the charity's fundraising telethon is included in the fundraising ratio calculation, fundraising costs rise to 77% of donations (cash and donated media) and special events fundraising. This is far outside Ci's reasonable range for overhead spending. 

Stand Up to Cancer has $2.8m in funding reserves, which can cover annual program and grants spending (excluding donated goods) at the current level for one year and four months.  

SU2C Canada reports no paid staff in its most recent F2018 T3010 filing. 

SU2C Canada is closely related with the American-based Entertainment Industry Foundation (EIF). The two organizations share common directors. SU2C Canada has a licensing agreement with EIF wherein SU2C Canada must pay EIF a minimum royalty of 4% of 2020 annual gross revenue, reported as a commitment in the F2019 audited financial statements.  

This report is an update that has been sent to Stand Up to Cancer Canada for review. Comments and edits may be forthcoming. 

Updated on August 5, 2020 by Katie Khodawandi.  

Financial Review


Financial Ratios

Fiscal year ending December
201920182017
Administrative costs as % of revenues 1.3%3.0%3.5%
Fundraising costs as % of donations 0.0%7.2%0.4%
Total overhead spending 1.3%10.2%3.9%
Program cost coverage (%) 137.0%128.9%412.4%

Summary Financial Statements

All figures in $000s
201920182017
Donations 1,6981,4931,444
Goods in kind 15,6966,3084,572
Special events 05940
Other income 636939
Total revenues 17,4578,4646,055
Program costs 409389142
Grants 1,6172,5801,048
Donated goods exp 15,6966,3084,572
Administrative costs 231254212
Fundraising costs 01506
Total spending 17,9539,6805,981
Cash flow from operations (496)(1,217)75
Capital spending 000
Funding reserves 2,7753,8284,910

Note: To report on a cash basis, Ci adjusted grants for changes in grants payable, affecting total expenses by $671k in F2019, $233k in F2018 and ($676k) in F2017. Fundraising revenue is reported gross of direct expenses, increasing total revenue and expenses by $76k in F2018 and $347 in F2017. Donated goods in kind includes donated media of $15.7m in F2019, $6.3m in F2018, and $4.6m in F2017.  The audited financials report no capital spending.

Salary Information

Full-time staff: 0

Avg. Compensation: $0

Top 10 staff salary range:

$350k +
0
$300k - $350k
0
$250k - $300k
0
$200k - $250k
0
$160k - $200k
0
$120k - $160k
0
$80k - $120k
0
$40k - $80k
0
< $40k
0

Information from most recent CRA Charities Directorate filings for F2018

My anchor

Comments & Contact

Comments added by the Charity:

No comments have been added by charity

Charity Contact

Website: www.standuptocancer.ca
This email address is being protected from spambots. You need JavaScript enabled to view it.

Print